TABLE 2.
Proportions of sera fulfilling different diagnostic criteria according to the time elapsed after estimated time of infection
| Diagnostic test and diagnostic criterion | % of samples fulfilling criterion at no. of wks after infection (no. of serum specimens examined)
|
||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 (14) | 2 (13) | 3 (6) | 4 (10) | 5 (9) | 6–10 (22) | 11–15 (13) | 16–20 (10) | 21–52 (29) | |
| Dye test | |||||||||
| ≥3 IU/ml | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| ≥300 IU/ml | 0 | 0 | 0 | 40 | 56 | 68 | 62 | 70 | 31 |
| Platelia Toxo-IgG | |||||||||
| ≥6 IU/ml | 0 | 100 | 100 | 82 | 89 | 100 | 100 | 100 | 97 |
| Toxo-Screen DA IgG | |||||||||
| Titer, ≥40 | 50 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Platelia Toxo-IgM | |||||||||
| ≥100% | 93 | 100 | 100 | 100 | 100 | 91 | 92 | 100 | 76 |
| Toxo-ISAGA IgM | |||||||||
| Index, ≥6 | 100 | 100 | 100 | 100 | 89 | 100 | 85 | 90 | 79 |
| Index, ≥9 | 93 | 90 | 100 | 100 | 89 | 100 | 77 | 90 | 76 |
| Platelia Toxo-IgA | |||||||||
| ≥100% | 21 | 82a | 67 | 50 | 75b | 77 | 62 | 60 | 45 |
Eleven sera were examined.
Seven sera were examined.